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Background: Molybdopterin cofactor (MoCo) biosynthesis in Mycobacterium tuberculosis is associated with a
multiplicity of genes encoding several enzymes in the pathway, including the molybdopterin (MPT) synthase, a
hetero tetramer comprising two MoaD and two MoaE subunits. In addition to moaD1, moaD2, moaE1, moaE2, the
M. tuberculosis genome also contains a moaX gene which encodes an MPT-synthase in which the MoaD and MoaE
domains are located on a single polypeptide. In this study, we assessed the requirement for post-translational
cleavage of MoaX for functionality of this novel, fused MPT synthase and attempted to establish a functional
hierarchy for the various MPT-synthase encoding genes in M. tuberculosis.
Results: Using a heterologous Mycobacterium smegmatis host and the activity of the MoCo-dependent nitrate
reductase, we confirmed that moaD2 and moaE2 from M. tuberculosis together encode a functional MPT synthase.
In contrast, moaD1 displayed no functionality in this system, even in the presence of the MoeBR sulphurtransferase,
which contains the rhodansese-like domain, predicted to activate MoaD subunits. We demonstrated that cleavage
of MoaX into its constituent MoaD and MoaE subunits was required for MPT synthase activity and confirmed
that cleavage occurs between the Gly82 and Ser83 residues in MoaX. Further analysis of the Gly81-Gly82 motif
confirmed that both of these residues are necessary for catalysis and that the Gly81 was required for recognition/
cleavage of MoaX by an as yet unidentified protease. In addition, the MoaE component of MoaX was able to
function in conjunction with M. smegmatis MoaD2 suggesting that cleavage of MoaX renders functionally
interchangeable subunits. Expression of MoaX in E. coli revealed that incorrect post-translational processing is
responsible for the lack of activity of MoaX in this heterologous host.
Conclusions: There is a degree of functional interchangeability between the MPT synthase subunits of M. tuberculosis.
In the case of MoaX, post-translational cleavage at the Gly82 residue is required for function.
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Mycobacterium tuberculosis has an expanded genetic
repertoire in several metabolic pathways, including those
involved in energy metabolism, cell wall biosynthesis
and DNA repair, a feature that is predicted to contribute
to the enhanced metabolic responsiveness of this or-
ganism under stressful environmental conditions [1-4].
This capacity is illustrated by the first two steps of the* Correspondence: bavesh.kana@nhls.ac.za
1DST/NRF Centre of Excellence for Biomedical TB Research, Faculty of Health
Sciences, University of the Witwatersrand, National Health Laboratory Service,
P.O. Box 1038, Johannesburg 2000, South Africa
Full list of author information is available at the end of the article
© 2015 Narrandes et al.; licensee BioMed Cen
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
unless otherwise stated.pathway for the biosynthesis of molybdopterin cofactor
(MoCo), which is synthesized through a multi-step path-
way that requires the input of several proteins at each
step [4-8]. Genes involved in MoCo biosynthesis and
those encoding molybdoenzymes have been implicated
in the pathogenesis of M. tuberculosis ([9] and reviewed
in [4,10]). Molybdoenzymes facilitate redox reactions in
carbon, nitrogen and sulphur metabolism in a diversity
of eukaryotes and archea [8]. These findings, together
with the proposed importance of this cofactor for patho-
genesis, suggest that MoCo biosynthesis is a potentially
interesting pathway for further understanding the life-
style of the tubercle bacillus during infection.tral. This is an Open Access article distributed under the terms of the Creative
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the pathway via a reaction which is catalyzed by the het-
erotetrameric MPT synthase, an enzyme comprising a
pair of associated MoaD-MoaE heterodimers [6,8,11-13]
(Figure 1A). The two sulphur molecules which are trans-
ferred to cyclic pyranopterin monophosphate (cPMP)
are carried on the C-terminal glycine of MoaD as a thio-
carboxylate. In order for the synthase to remain cataly-
tically active, the sulfur on the C-terminus of MoaD
must be regenerated in a series of steps (Figure 1A)
[5,14]. MoeB is responsible for the ATP-dependent
activation of the C-terminus of MoaD to form MoaD-
adenylate [15], a reaction which requires the dissociation
of MoaD from MoaE and formation of a MoeB-MoaD
complex [16]. Studies in Escherichia coli have shown
that the adenylated MoaD is then sulfurated by the cyst-
eine desulphurase, IscS [17], an enzyme which acts as a
sulfur donor in various reactions, including those required
for the biosynthesis of biotin, thiamin and lipoic acid [18].
It was recently demonstrated that a rhodanese-like pro-
tein, YnjE, is required to direct IscS to MoCo biosynthesis
in E. coli [19]. The formation of MPT proceeds via an
intermediate carrying a single sulphur molecule and a
terminal phosphate group, which remains tightly bound to
the MoaE dimer. The conversion of the intermediate to
MPT requires the dissociation of the uncharged MoaD
and binding of a second thiocarboxylated MoaD [15].
In M. tuberculosis, the genes encoding MPT synthase
subunits include moaD1, moaD2, moaE1, moaE2 (referred
to herein as Mtb moaD1, Mtb moaD2, Mtb moaE1, and
Mtb moaE2) and moaX, where the latter encodes a fused
molybdopterin synthase with MoaD- and MoaE-like do-
mains located on a single polypeptide [4,20] (Figure 1B).
In previous work, we demonstrated that Mtb moaD1, Mtb
moaD2 and moaX all contribute to molybdopterin biosyn-
thesis in M. tuberculosis [21]. The presence of moaX in
the genus Mycobacterium is restricted to those pathogenic
mycobacteria that comprise the M. tuberculosis com-
plex [21]. The demonstrated functionality of this atypical
MPT-synthase-encoding gene suggests that it may serve a
specific cellular function in pathogenesis [21]. However,
the prevailing biochemical evidence pertaining to the cata-
lytic mechanism of MPT synthase in E. coli [11,22] sug-
gests that MoaX is likely to be non-functional as a single
polypeptide for the following reasons: (I) In its active
form, MoaD is thiocarboxylated at a C-terminal glycine
(Gly) residue [5,22]. (II) During the formation of MPT, the
sulfur atom on the C-terminus of MoaD is transferred to
cPMP, bound in the substrate pocket of MoaE, which can
accommodate both the C-terminus of MoaD as well as
MPT or cPMP [22]; in this context, it is unlikely that the
fused MoaX would accommodate this catalytic process.
(III) MoaD, like ubiquitin, contains a C-terminal Gly-Gly
motif which has been shown to be important for thefunction and stability of MPT synthase [23], and deletion,
insertion or substitution mutants of these revealed that
the terminal Gly residue (Gly81 in E. coli MoaD –
corresponding to Gly82 in MoaX from M. tuberculosis,
Figure 1B) and the penultimate Gly (Gly80 in E. coli
MoaD – corresponding to Gly81 in MoaX from M. tuber-
culosis, Figure 1B) are essential for MPT synthase activity.
(IV) Substitution of either Gly residue did not affect the
ability to form a MoaD-MoaE heterodimer complex, al-
though the G81A substitution in E. coli slowed complex
formation by 60%, thus identifying this residue as essential
for optimal MPT synthase function [23]. In MoaX, the
corresponding Gly81-Gly82 residues are not located at the
C-terminus but rather reside within the polypeptide chain
(Figure 1B), thus suggesting that cleavage of MoaX into its
MoaD and MoaE components is required in order to lib-
erate the terminal glycine residues to mediate the above-
mentioned functions.
M. tuberculosis contains two rhodanese-like proteins,
MoeBR and MoeZR (previously annotated as MoeB2
and MoeB1, respectively), which are predicted to be in-
volved in MoCo biosynthesis; both of these proteins are
able to catalyze the sulphuration of MoaD1 and MoaD2
[24]. In prior work, we demonstrated that MoaD1 from
M. tuberculosis was not functional in M. smegmatis [21],
a finding which we ascribed to the lack of the corre-
sponding rhodanese-like protein in M. smegmatis. In the
present study, we investigate whether cleavage of MoaX
is necessary for functionality of the resulting subunits.
We also assess whether the presence of the rhodanese-
like protein, MoeBR, is necessary for the function of
M. tuberculosis MoaD homologues in M. smegmatis.
Results
Functional analysis of MPT synthase encoding genes from
M. tuberculosis
The proteomes of M. tuberculosis and M. smegmatis are
predicted to contain 7 and 20 molybdoenzymes res-
pectively; included among these are respiratory and/or
assimilatory nitrate reductase (NR) enzymes [4]. In M.
tuberculosis, the membrane-bound NR, NarGHI, is the
only NR present and it serves both respiratory and assimi-
latory functions [25]. In addition to NarGHI, M. smegma-
tis possesses an additional narB-encoded assimilatory NR,
which is also predicted to be a molybdoenzyme [4]. In
prior work, we developed an assay for MoCo availability
in M. smegmatis which is based on measuring growth on
nitrate as the sole nitrogen source via MoCo-dependent
NR activity. We used this assay to confirm the essentiality
of the sole MPT synthase subunit-encoding genes in this
organism, designated herein as Msm moaD2 and Msm
moaE2 [21] (Figure 1A), for MoCo biosynthesis. This
growth-based assay thus provided a convenient means of
evaluating the ability of various combinations of M.
Figure 1 Schematic representation of the proposed pathway for MPT formation from cPMP and sequence analysis of MoaX. (A) MPT
synthesis is catalyzed by the heterotetrameric MPT synthase, which is made up of two MoaD (Green-Active, Yellow-Inactive) and two MoaE (Red)
subunits. S – Sulphur. The MPT synthase encoding genes in M. smegmatis and M. tuberculosis are shown to highlight the multiplicity of homologues in
M. tuberculosis. Adapted from [14,17,22]. (B) Sequence alignment of E. coli MoaD (ECDH10B_0852) and MoaE (ECDH10B_0853), Mtb MoaD1 (Rv3112),
Mtb MoaD2 (Rv0868c), Mtb MoaE1 (Rv3119), Mtb MoaE2 (Rv0866) and MoaX (Rv3323c) proteins. Conserved Gly residues are shown in red, these
correspond to positions 81 and 82 in MoaX. The M. tuberculosis MoaX sequence is highlighted in bold; the MoaD component is shown in the green
box and the MoaE component in the red box. The Alignment was generated using sequences obtained from Tuberculist (http://genolist.pasteur.fr/
TubercuList/) and the Clustal Omega (http://www.ebi.ac.uk/Tools/msa/clustalo/) online alignment tool.
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MPT synthase activity. We first tested if a double mutant
of M. smegmatis lacking Msm moaD2 and Msm moaE2
(ΔmoaD2 ΔmoaE2) carrying combinations of the Mtb
moaD1, Mtb moaD2, Mtb moaE1, or Mtb moaE2 genes,
on vectors that integrated into the mycobacterial chromo-
some (Additional file 1: Table S1), displayed detectable NR
activity. None of the combinations of M. tuberculosis
genes tested was able to restore NR-dependent growth of
the M. smegmatis ΔmoaD2 ΔmoaE2 mutant when pro-
vided in single copy via an integration vector (Table 1,
Additional file 1: Figure S1). To test whether the lack of
functional complementation was attributable to a low
level of gene expression, we used qRT-PCR to assess gene
expression levels in the various M. smegmatis recombi-
nants. However, this analysis confirmed that in all cases,
the M. tuberculosis genes were expressed at levels higher
than the native Msm moaD2 and Msm moaE2 genes in
wild typeM. smegmatis (Figure 2A).
In prior work, we had demonstrated the functionality
of Mtb moaD2, Mtb moaE1 and Mtb moaE2 through
complementation of M. smegmatis mutants lacking
either Msm moaD2 or Msm moaE2 by delivering the M.
tuberculosis genes on an episomal plasmid [21], as
opposed to an integrative vector. We therefore con-
structed synthetic operons carrying pairs of M. tubercu-
losis moaD and moaE homologs under the control of
the mycobacterial hsp60 promoter (Additional file 1:
Table S2) and cloned these on an episomal plasmid. The
resulting constructs were introduced into M. smegmatis
ΔmoaD2 ΔmoaE2 and the resulting strains assessed forTable 1 The ability of MPT-synthase encoding genes from
M. tuberculosis to restore MoCo biosynthesis in the





Mtb moaD1 +Mtb moaE1 Integration No
Mtb moaD1 +Mtb moaE2 Integration No
Mtb moaD2 +Mtb moaE1 Integration No
Mtb moaD2 +Mtb moaE2 Integration No
Mtb moaD1+ Mtb moaE1 Episomal No
Mtb moaD1+ Mtb moaE2 Episomal No
Mtb moaD2+ Mtb moaE1 Episomal No






*As measured by the ability to restore growth of the M. smegmatis ΔmoaD2
ΔmoaE2 mutant on nitrate as sole nitrogen source. §Carried on pFLAGEM, with
a C-terminal 3 × FLAG-tag.MoCo-dependent growth on nitrate as sole nitrogen
source. As observed by Williams et al. [21], episomally
expressed moaX was able to restore MoCo biosynthesis
in the ΔmoaD2 ΔmoaE2 mutant (Figure 2B). However,
of the various combinations of M. tuberculosis genes
tested, only the combination of Mtb moaD2 and Mtb
moaE2 reconstituted MoCo biosynthesis, as evidenced
by growth restoration of the double mutant (Figure 2B,
Table 1). In contrast, none of the synthetic operon con-
structs carrying Mtb moaD1 proved to be functional
(Table 1) despite achieving gene expression levels compar-
able to, or higher than, the native Msm moaD2 or Msm
moaE2 genes in wild typeM. smegmatis (Figure 2A).
The lack of functionality of the M. tuberculosis Mtb
moaD2-Mtb moaE1 combination, when expressed epi-
somally as a synthetic operon was surprising since these
genes had been shown to individually complement single
deletion mutants of M. smegmatis lacking either Msm
moaD2 or Msm moaE2 [21]. We reasoned that this dis-
crepancy might be due to differences in maturation of
the MPT synthase or in sulphur metabolism between
these organisms. Furthermore, the lack of functionality
of Mtb moaD1 in M. smegmatis was previously ascribed
to the absence of moeBR in this organism which is pro-
posed to preferentially interact with MoaD1 in M. tuber-
culosis since some mycobacterial strains have MoeZR
and MoaD2 only, with no MoaD1 and MoeBR homo-
logues [4,21,24]. In order to further assess the preferen-
tial requirement of MoeBR to activate Mtb MoaD1,
moeBR from M. tuberculosis was expressed on an op-
eron with Mtb moaD1 and Mtb moaE2 and delivered
into the M. smegmatis ΔmoaD2 ΔmoaE2 mutant on an
episomal vector. Expression analysis of the recombinant
strain identified moeBR transcript at a level equivalent to
that of Mtb moaD1 (Additional file 1: Figure S2A). How-
ever, this strain was unable to grow on nitrate in min-
imal medium (Additional file 1: Figure S2B).
MoaX is cleaved to yield two functional MPT synthase
subunits
The active site of the MPT synthase is located within a
pocket of MoaE and contains conserved C-terminal Gly
residues of MoaD which are directly involved in enzyme
activity [22]. We therefore hypothesized that MoaX
might be post-translationally processed into MoaD and
MoaE components in order to provide access to the
residues Gly81 and Gly82 in the MoaD component of
MoaX for further chemical modification. To test this, we
first created a derivative of MoaX carrying a C-terminal
FLAG-tag, termed MoaXFL. The MoaXFL derivative
was fully proficient at restoring MoCo biosynthesis in
the M. smegmatis ΔmoaD2 ΔmoaE2 mutant, confirming
that the FLAG-tag did not disrupt MPT synthase activity
(Figure 3A, Table 1). Western blot analysis of a cell
Figure 2 Analysis of gene expression and MoCo biosynthesis in genetically complemented strains. (A) Comparison of heterologous gene
expression levels from integrating (single copy) versus episomal (multicopy) complementing vectors. The expression level of each gene was
normalized against the expression of the sigA gene. In all cases, the data shown are representative of three independent biological replicates with
standard errors of the mean. The expression of moaD2 and moaE2 in wild type (WT) M. smegmatis and the expression of moaX, when provided
in single copy (pTX) or multicopy (pMX) was also assessed for comparison. (B) Nitrate assimilation in strains complemented with episomal vectors
carrying different combinations of MPT-synthase-encoding genes. Strains were grown in MPLN medium supplemented with 10 mM Nitrate as the
sole nitrate source.
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rected to the FLAG-tag, revealed the presence of two
major bands, which corresponded to the predicted sizes
for full-length MoaXFL (26.5 kDa) and the FLAG-tagged
MoaE domain of MoaX (17.8 kDa), respectively (Figure 3B).
Peptide mass fingerprinting confirmed the presence of
MoaE peptides in the 17.8 kDa band, with the terminal
residue of one of the peptides corresponding to the Gly82residue in MoaD (Figure 3C). No peptides that spanned
the MoaD-MoaE junction were identified. These data
confirmed cleavage at the Gly82 motif in MoaX to yield
canonical MoaD and MoaE subunits. The presence of re-
sidual full length MoaX suggested that MoaX processing
might be condition dependent. To further investigate this,
we tested the extent of MoaX cleavage under different
growth conditions, which included 7H9 broth or MPLN
Figure 3 FLAG-tagged MoaX is functional and cleaved in M. smegmatis. (A) Nitrate assimilation in the ΔmoaD2 ΔmoaE2 mutant with a
C-terminal FLAG-tagged derivative of moaX. In all cases, genes were expressed constitutively from the tetO operator. (B) Western blot analysis
of protein extract from ΔmoaD2 ΔmoaE2 carrying C-terminally FLAG-tagged moaX showing cleavage of the fused MPT synthase at the Gly82
residue. Incorporation of the FLAG tag did not interrupt the function of MoaX, evidenced by the retained ability of the FLAG-tagged derivative to
restore growth of ΔmoaD2 ΔmoaE2 in MPLN. (C) Peptide fragments of MoaX identified by mass spectrometry. Shown are two peptide fragments
for each fraction. Red indicates the terminal Gly residues. Peptide reads all stopped at the Gly82 position, indicating cleavage at this point.
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of cleavage under these conditions (Additional file 1:
Figure S3).
The Gly81-Gly82 motif in MoaX is necessary for cleavage
and function
As outlined above, the two terminal Gly residues in MoaD
have been identified as important for MPT synthase acti-
vity in E. coli [23]. Sequence alignment of MoaX with Mtb
MoaD1 and Mtb MoaD2 as well as with E. coli MoaD re-
veals that these Gly residues, Gly81 and Gly82 (positions
in the M. tuberculosis enzymes), are conserved in MoaX
(Figure 1B). In order to assess whether these residues are
important for MoaX function and/or cleavage, site-
directed mutagenesis of the moaXFL gene was carried out
to individually replace each Gly with an Ala. MoCobiosynthesis was then assessed in strains carrying the
corresponding mutant moaXFLG81A or moaXFLG82A al-
leles. Unlike wild type MoaXFL, the mutant derivatives,
MoaXFLG81A and MoaXFLG82A, were unable to restore
MoCo biosynthesis in the MPT-synthase deficient mutant
of M. smegmatis (Figure 4A, Table 1). In addition to being
essential for functionality, Western blot analysis revealed
that Gly81 is also required for cleavage of MoaX since no
discernible cleavage was detected for the MoaXFLG81A
mutant protein (Figure 4B). In contrast, while essential for
function, Gly82 did not appear to be required for MoaX
processing as evidenced by the presence of a 17.8 kDa
MoaE band in the Western blot analysis of the strain ex-
pressing MoaXFLG82A (Figure 4B).
The mutated Gly81/Gly82 residues form part of the
MoaD component of MoaX, suggesting that once
Figure 4 Cleavage of MoaX is necessary for function. (A) Nitrate assimilation in strains carrying FLAG-tagged mutated derivatives of MoaX.
Shown are strains carrying either a G81A or G82A mutation. (B) Western blot analysis. An antibody directed at the FLAG-tag was used (C) Nitrate
assimilation in the ΔmoaE2 single mutant of M. smegmatis. Growth curves were performed in MPLN medium with cell density measured over a
period of 5 days. The G81A mutation abolished cleavage, whereas mutation G82A did not interfere with processing, but yielded a non-functional
MoaD subunit. All data represent the result of three independent experiments.
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main active. In order to test this, the vectors expressing
MoaXFLG81A or MoaXFLG82A were introduced into the
M. smegmatis ΔmoaE2 single mutant and the recombin-
ant strains assessed for growth on nitrate as sole nitro-
gen source. MoCo biosynthesis was restored in the
strain expressing MoaXG82A (Figure 4C), which con-
firmed that the Mtb MoaE subunit released through
cleavage of MoaX can associate with Msm MoaD2 to re-
constitute a functional, chimeric MPT synthase. In con-
trast, the ΔmoaE2 strain expressing the non-functional,
un-cleavable MoaXFLG81A was severely attenuated for
growth on nitrate as sole nitrogen source (Figure 4C),
providing further evidence that MoaX cleavage is indeed
required for the function of the resulting MoaE subunit.
Finally, a recent study revealed that M. tuberculosis
moaX was unable to complement E. coli moaD or moaE
single mutants [24]. The authors of this study hypothe-
sized that this was due to the lack of MoaX cleavage ma-
chinery in E. coli. We addressed this question by
Western blot analysis of protein extracts from E. colicells expressing MoaXFL. Full-length MoaXFL as well as
a minor band of higher molecular weight than expected
for the MoaE subunit were observed in the Western
blot. However, in contrast to the M. smegmatis control,
a band corresponding to the FLAG-tagged MoaE com-
ponent of MoaX was not observed in the E. coli extract
(Figure 5).
Discussion
M. tuberculosis has a multiplicity of MPT-synthase-
encoding genes which all contribute to MoCo biosyn-
thesis [4]. The observation that chimeras of MPT syn-
thase from different combinations of human and E. coli
subunits display varying catalytic efficiencies [26], to-
gether with the demonstrated functionality of the Mtb
moaD1, Mtb moaD2, Mtb moaE1, and Mtb moaE2
genes [21], raised the possibility that different isoforms
of MPT synthase might occur in M. tuberculosis. How-
ever, only a combination of Mtb moaD2 and Mtb
moaE2, when expressed at high levels from an episomal
plasmid in M. smegmatis, was able to complement the
Figure 5 Western blot analysis of MoaXFL in E. coli. Included as
a positive control is protein extract from M. smegmatis expressing
moaX from the same system. The correct 26.5 kDa band corresponding
to un-cleaved MoaX is observed in both organisms. However, the
17.8 kDa cleavage product corresponding to the MoaE component of
MoaX is not observed in E. coli, which displays a larger (~20 kDa) band.
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mutant; none of the other combinations of Mtb moaD
and moaE homologues that were tested formed a func-
tional MPT synthase. The expression levels of comple-
menting genes in strains carrying Mtb moaE1, either on
integrative or episomal vectors, were all relatively low
when compared to those carrying Mtb moaE2, sug-
gesting that an expression threshold may be required in
order to achieve functional complementation in the
heterologous host. Importantly, however, moaX com-
plemented the growth phenotype of the double mutant
when expressed from an integrative vector at a comparably
low level, suggesting that a factor/s other than expression
level was responsible for the differential complementing
abilities of the Mtb moaD/moaE combinations.
In E. coli, MoeB adenylates MoaD which is subse-
quently sulfurated by IscS and a rhodanese-like protein,
YnjE, to generate the thiocarboxylated form of MoaD re-
quired for MPT formation [17,19]. In M. tuberculosis,
both MoeBR and MoeZR contain a rhodanese-like do-
main and are capable of sulfur transfer in vitro to Mtb
MoaD1 and Mtb MoaD2 [24]. However, the amino acid
sequence of Mtb MoaD2 is more closely related to the
sulphur carrier protein, CysO, than to Mtb MoaD1. This
observation, together with the fact that CysO is a prefer-
ential substrate for MoeZR, has led to the hypothesis
that Mtb MoaD1 is preferentially activated by MoeBR,
while Mtb MoaD2 is activated by MoeZR [24]. This is
supported by the fact that other mycobacteria, including
Mycobacterium avium 104, Mycobacterium marinum and
Mycobacterium ulcerans, contain MoaD2 and MoeZR,
but not MoaD1 and MoeBR homologues [9,21]. Impor-
tantly, both Mtb MoaD1 and MoeBR are located on amobile genetic cluster that was acquired by horizontal
gene transfer [27] thus further supporting the notion that
MoeBR preferentially activates Mtb MoaD1.M. smegmatis
possesses a single moaD gene (moaD2) and moeZR sug-
gesting that the lack of functionality of Mtb MoaD1 in this
organism could be attributable to differences in the
complement of enzymes with a rhodanese-like domain.
However, inclusion of moeBR in an expression cassette
carrying Mtb moaD1 and Mtb moaE2 did not result in
functional complementation of the MoCo biosynthesis
defect of the ΔmoaD2 ΔmoaE2 mutant. This suggests that
the lack of functionality for Mtb moaD1 may be due to
other reasons such as differences in the complement
sulphur carrier proteins, and/or in cysteine biosynthesis.
In E. coli, CysO is involved in cysteine biosynthesis
[24], which highlights a role for MoeZR in both amino
acid and MoCo biosynthesis, thus linking these meta-
bolic pathways. Cysteine has been implicated in M. tu-
berculosis pathogenesis by providing protection against
reactive oxygen/nitrogen intermediates [28]; this also
suggests a role for MoeZR under these conditions, which
is supported by the up-regulation of cysM, cysO and
moeZR in M. tuberculosis under oxidative stress [29].
The mycobacterial sulfur source for MoCo biosynthesis
remains unknown but is most likely L-cysteine [24,30],
in which case, an L-cysteine desulphurase such as IscS
would transfer sulfur to MoeZR. In E. coli, IscS is impli-
cated in iron-sulfur cluster homeostasis [31] and may
have a similar role in mycobacteria which, through an
interaction with MoeZR, would link iron-sulfur cluster
homeostasis with the second step of MoCo biosynthesis.
It is therefore reasonable to conclude that disruptions in
the MPT synthase step of the pathway would not only
affect MoCo biosynthesis but might also disturb cysteine
biosynthesis and sulfur homeostasis. Consistent with this
is the large number of transposon mutants of M. tuber-
culosis which map to the first two steps of the MoCo
biosynthesis pathway and are defective for intracellular
growth or survival in animals [32-37].
Structural analysis of the E. coli MPT synthase re-
vealed that the essential terminal Gly residue of MoaD is
embedded in a pocket of MoaE where the sulphur
transfer reaction occurs [11]. Considering this domain
organization and catalysis sequence, it was unclear how
the single polypeptide, encoded by moaX would be able
to function. In this study, we demonstrated cleavage of
MoaX and further studied the role of the Gly81-Gly82
residues; a model that describes our findings is shown in
Figure 6. The Gly81 residue is required for proteolytic
processing and the inability of the MoaXFLG81A mutant
protein to restore MoCo biosynthesis confirmed that
cleavage of MoaX is necessary for catalysis. This is
corroborated by the ability of the non-functional but
cleaved MoaXFLG82A mutant protein to restore MPT
Figure 6 The role of the Gly81-Gly82 residues in MoaX. The Gly81 and Gly82 residues in MoaX are required for functionality. Mass spectrometry
analysis of MoaX cleavage products confirmed that proteolytic processing occurs between the Gly82-Ser83 motifs to yield two functional MPT-synthase
subunits. Mutation of Gly81 abrogates processing, yielding a non-functional, uncleaved derivative of MoaX suggesting that this residue is important for
recognition/binding of the protease. In contrast, the G82→A mutation does not affect cleavage but the resulting MoaD-like subunit is not functional
due to the absence of the terminal glycine, which is required for activation of MoaD by MoeB. However, the MoaE subunit that results from cleavage of
this mutant protein can combine with the Msm MoaD2 to reconstitute a functional enzyme.
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functional Msm MoaD2. In this case, MoCo biosynthesis
is restored through the activity of a chimeric Msm
MoaD2- Mtb MoaE enzyme, confirming that cleavage of
MoaX releases functionally interchangeable subunits.
However, we cannot rule out the possibility that muta-
tion of the Gly81 residue in the un-cleaved protein may
also contribute to lack of function. The identification of
residual full-length MoaX for all cases in which cleavage
was observed suggests that in M. smegmatis, the cleav-
age process is either slow or subject to regulation.
Finally, a recent study by Voss et al. [24], established
that MoaX was not functional in E. coli and was unable
to interact with either MoeBR or MoeZR from M. tuber-
culosis. The authors speculated that this was due to the
lack of the MoaX cleavage machinery in E. coli as op-
posed to an inherent inability of these proteins to inter-
act. In this study, we demonstrated that some cleavageof MoaX does occur when constitutively expressed in E.
coli DH5α; however, the cleavage product was larger
than expected, which might explain the inability of
MoaX to function in E. coli.
Conclusions
In conclusion, we have demonstrated that there is a de-
gree of functional interchangeability between the MPT
synthase subunits of M. tuberculosis. In the case of
MoaX, post-translational cleavage at the Gly82 residue is
required for functionality of this novel MPT synthase.
Methods
Bacterial strains and culture conditions
The bacterial strains used and generated during this study
are listed in Additional file 1: Table S1. E. coli strains
were grown in Luria Bertani liquid medium (LB) or
solid medium (LA) supplemented with the appropriate
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(Hyg) and 50 μg/ml Kanamycin (Kan). M. smegmatis
strains were grown in Middlebrook 7H9 liquid me-
dium (Difco) supplemented with Middlebrook oleic acid-
albumin-dextrose-catalase (OADC) enrichment (Difco),
0.2% glycerol and 0.05% Tween80, with shaking, or on
Middlebrook 7H10 solid medium (Difco) supplemented
with 0.085% NaCl, 0.2% glucose and 0.5% glycerol. Media
for M. smegmatis growth was supplemented with antibio-
tics at concentrations of 50 μg/ml Hyg and/or 25 μg/ml
Kan where appropriate. Nitrate assimilation to measure
MoCo biosynthesis was carried out as previously de-
scribed in [21]. Briefly, pre-cultures were washed and in-
oculated into modified Mycobacterium phlei minimal
medium (MPLN), which was modified by excluding as-
paragine and substituting with 10 mM sodium nitrate, in
a final volume of 10 ml to an optical density at 600 nm
(OD600) of 0.05. Cultures were monitored for 5 days with
OD600 readings recorded daily. All cultures were incu-
bated at 37°C, with shaking at 115 rpm.
Complementation vector constructions
The multi-copy episomal vectors (pTBD1, pTBD2, pTBE1
and pTBE2), carrying each of the M. tuberculosis moaD
and moaE homologues, provided by Dr. M. Williams [21],
were used for the construction of vectors in the present
study. Using the restriction enzymes BglII and PvuI, the
genes, together with their hsp60 promoters were excised
from these vectors. The integrating vectors, pTT1B and
pHINT, were linearized with ScaI. Mtb moaE1 and Mtb
moaE2 fragments were ligated to linearized pTT1B to
generate the integrating vectors, pTE1 and pTE2,
respectively. The Mtb moaD1 and Mtb moaD2 genes
were similarly incorporated into pHINT, forming the
vectors pHD1 and pHD2, respectively. An integrating
vector carrying moaX was similarly constructed by ex-
cising the gene together with its hsp60 promoter from
pMoaX [21] with SacII and ligating it to the ScaI-linear-
ized pTT1B vector, to generate the integrating vector,
pTX. Details of the vectors are provided in Additional
file 1: Table S2.
Episomal vectors carrying different combinations of the
M. tuberculosis moaD and moaE homologues were con-
structed using a PCR cloning strategy. This strategy
allowed for the introduction of Mtb moaD1 and Mtb
moaD2 upstream of both Mtb moaE1 and Mtb moaE2
carried on episomal vectors, and facilitated the operonic
expression of two genes driven off a single hsp60 pro-
moter. The primers, mD1F and mD1R, were used to amp-
lify Mtb moaD1, while mD2F and mD2R were used to
amplify Mtb moaD2. The purified PCR products as well
as the vectors pTBE1 and pTBE2 were digested with PstI
and HindIII to allow for directional cloning. The digested
fragments were ligated together in different combinationsto generate the episomal vectors pMD1E1, pMD1E2,
pMD2E1 and pMD2E2.
The primers moeBRF and moeBRR were used to amp-
lify M. tuberculosis moeBR from genomic DNA. The
1178 bp PCR product was digested with PacI while the
vector pMD1E2 was digested with PstI. Both fragments
were blunted and ligated to generate the plasmid
BRD1E2. Details of primers are provided in Additional
file 1: Table S3.
FLAG-tagging of proteins
The FLAG-tag vector pFLAGEM, carrying a 3 × FLAG-
tag [38], was generated by ligating a double stranded
linker with overhangs compatible to the SphI and HindIII
sites, to replace the SphI to HindIII fragment of pSE100.
The linker was designed with a nucleotide bias towards in-
creased G + C content, while retaining the same peptide
sequence. Placement of BsrGI and Acc65I sites allows for
cloning the same PCR fragment to create either N- or C-
terminally FLAG-tagged proteins. The primers moaXF
and moaXR (Additional file 1: Table S3) were used to
amplify moaX. The 679 bp PCR product was digested with
BsrGI and BsiWI prior to ligation. The digested PCR
fragment was ligated with BsrGI digested pFLAGEM for
incorporation of the tag at the C-terminus of MoaX to
generate pMoaXFL (Additional file 1: Table S2).
Mutagenesis vector constructions
The Megaprimer method [39] was used to introduce
two independent point mutations into moaX. The
primers used are listed in Additional file 1: Table S3.
The mutated reverse primer moaXga1R was used to in-
corporate the 242G→C point mutation into moaX
which resulted in a Gly→Ala change at position 81 of
MoaX. A second mutated reverse primer moaXga2R was
used to incorporate the 245G→C point mutation into
moaX which resulted in a Gly→Ala change at position
82 of MoaX. Full-length mutated moaX genes were
cloned into pFLAGEM in the same manner as the wild
type gene. All of the vectors generated in this study were
confirmed by restriction analysis and sequencing.
Protein extractions
Cultures were grown in 50 or 100 ml of 7H9 medium to
an OD600 of 1–1.4 and harvested by centrifugation at 2
360 × g for 10 min. Pellets were then re-suspended in
B-PER (Fischer Scientific) cocktail solution (250 μl/
50 ml culture) and either stored at - 80°C or lysed im-
mediately. For lysis, cells were transferred to Lysing
Matrix B (IEPSA) tubes which contain 0.1 μm silica
beads for the mechanical shearing of cells. Cells were
lysed by ribolysing the tubes in the FastPrep Savant
FP-120 Ribolyser for 20 sec at speed 6 with three repeats
and 5 min incubations on ice between each run. The
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the cell debris and silica beads. The supernatant was
then transferred to clean tubes and centrifuged at
12 470 × g for 5 min to separate the soluble and in-
soluble protein fractions. MoaX was predominantly ob-
served in the soluble fraction. For the extraction of
protein from E. coli cells, 10-20-ml cultures were grown
in LB with the appropriate antibiotics and harvested by
centrifugation at 2 360 × g for 10 min. Cell pellets were
then re-suspended in 250–500 μl of B-PER cocktail and
incubated at room temperature for 10 min. Cell debris
was collected by centrifugation at 12 470 × g for 5 min
and the supernatant was used for downstream processes.
Western blot analysis
The primary antibody used for all Western blots in
this study was ANTI-FLAG M2® Monoclonal Antibody,
mouse-purified IgG (Sigma) at a final concentration of
10 μg/ ml and the secondary antibody used was Rabbit
Anti-Mouse IgG, Peroxidase Conjugate (Sigma) at a di-
lution of 1:25 000–40 000. Membranes were incubated
with the primary antibody for 1 hr at room temperature
or at 4°C overnight with gentle agitation. This was
followed by three washes in TBST (Tris-Buffered Saline
and Tween 20) for 5 min each. Incubations with the
secondary antibody were carried out for 1 hr at room
temperature with gentle shaking. This was followed by
five wash steps of 5 min each with TBST at room
temperature. Chemiluminescent Peroxidase Substrate
(CPS) Reagent (Sigma) was then added and the mem-
brane was exposed to X-ray film.
Protein identification
The nanoLC-MSMS based peptide sequencing method
was used to identify protein fragments excised from
Coomasie blue-stained gels. This analysis was performed
at the Council for Scientific and Industrial Research
(CSIR) in Pretoria, South Africa, Dr Stoyan Stoychev.
Mass spectrometry data was analyzed using ProteinPilot™
Software 3.0.
Quantitative Real-Time PCR
Cultures for RNA extraction were grown in 7H9
medium to an OD600 of 0.5 at which point cells were
harvested by centrifugation at 2 360 × g for 10 min. RNA
was extracted using the NucleoSpin RNA II Kit (Support
Protocol 5.3) as per manufacturer’s instructions. For
complete disruption of the mycobacterial cell wall, three
rounds of ribolyzing were performed at 4.5 for 45 s, with
cooling on ice for 2 mins between each round. RNA
conversion to cDNA was performed using 1 μg RNA
and SuperScript III (Life Technologies) as per the manu-
facturer’s instructions. RT PCR was performed using the
synthesized cDNA and Evagreen Supermix (Biorad) asper the manufacturers’ instructions. The primers used
for qRT PCR are listed in Additional file 1: Table S4. Ex-
pression of each gene was normalized against the sigA
expression level.Additional file
Additional file 1: Figure S1. Growth curve of M. smegmatis ΔmoaD2
ΔmoaE2 complemented with different combinations of Mtb moaD1, Mtb
moaD2, Mtb moaE1 and Mtb moaE2 carried on integrating vectors.
Growth curves were carried out in MPLN medium, supplemented with
10 mM sodium nitrate with optical density readings taken daily
for 5 days. The data are an average of at least three independent
experiments. Figure S2. MoeBR does not confer functionality with
MoaD1 homologues. (A) Gene expression analysis of M. smegmatis
double mutant strain complemented with Mtb moaD1, Mtb moaE2 and
moeBR. The expression of each gene was normalized against sigA
expression. Data were generated from three independent experiments.
(B) Nitrate assimilation in M. smegmatis strains. Growth curves were
carried out in MPLN, supplemented with 10 mM, sodium nitrate. The
growth curve is an average of four independent experiments with
standard errors. Figure S3. Cleavage of MoaX under different growth
conditions. Strains carrying pMoaXFL were transformed with pMC1s,
which carries the TetR repressor. In this case, the addition of
anhydrotetracycline induces expression of moaXFL. Cleavage was tested
in standard 7H9 broth and in MPLN media (A) MoaX cleavage in mc2155
(B) MoaX cleavage in ΔmoaD2 ΔmoaE2:: pMC1s (pMoaXFL). Table S1.
M. smegmatis strains used and generated during this study. Table S2.
Plasmids used and generated during this study. Table S3. Primers used
for construction of plasmids Table S4. Primers used for q(RT)PCR analysis.Abbreviations
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